Stratec SE (SBS.F)
- Previous Close
26.25 - Open
25.60 - Bid 25.70 x 20000
- Ask 26.05 x 20000
- Day's Range
25.60 - 25.60 - 52 Week Range
21.80 - 48.00 - Volume
40 - Avg. Volume
39 - Market Cap (intraday)
311.191M - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
19.39 - EPS (TTM)
1.32 - Earnings Date May 30, 2025
- Forward Dividend & Yield 0.60 (2.29%)
- Ex-Dividend Date Jun 30, 2025
- 1y Target Est
38.75
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
www.stratec.comRecent News: SBS.F
View MorePerformance Overview: SBS.F
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBS.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBS.F
View MoreValuation Measures
Market Cap
323.96M
Enterprise Value
405.76M
Trailing P/E
20.53
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.28
Price/Book (mrq)
1.36
Enterprise Value/Revenue
1.59
Enterprise Value/EBITDA
10.46
Financial Highlights
Profitability and Income Statement
Profit Margin
6.22%
Return on Assets (ttm)
3.98%
Return on Equity (ttm)
6.68%
Revenue (ttm)
257.62M
Net Income Avi to Common (ttm)
16.02M
Diluted EPS (ttm)
1.32
Balance Sheet and Cash Flow
Total Cash (mrq)
47.16M
Total Debt/Equity (mrq)
53.82%
Levered Free Cash Flow (ttm)
36.23M